What were the key stories in FiercePharma’s weekly watchlist roundup?

FiercePharma’s weekly watchlist highlighted three themes: a major psychedelics acquisition, a politically charged peptide advisory committee meeting, and a new legal clash between obesity drug leaders. The roundup framed them as signals of pharma’s 2026 backdrop of dealmaking, regulatory scrutiny and franchise defense.